Bay State Biotech Report: Paratek and Shire

Bay State Biotech Report
Paratek and Shire
Paratek is said to be weighing a sale, and Shire's CEO tells Bloomberg he's confident in growth amid pressure to raise its stock price. That's all on the Bay State Biotech Report, where Bloomberg biotechnology reporter and Boston radio host Anne Mostue discusses the latest in biotech news from the Boston area and across the nation.
Aug 23, 2017